OBJECTIVE: In 2004, results from The Texas Medication Algorithm Project (TMAP) showed better clinical outcomes for patients whose physicians adhered to a paper-and-pencil algorithm compared to patients who received standard clinical treatment for major depressive disorder (MDD). However, implementation of and fidelity to the treatment algorithm among various providers was observed to be inadequate. A computerized decision support system (CDSS) for the implementation of the TMAP algorithm for depression has since been developed to improve fidelity and adherence to the algorithm. METHOD: This was a 2-group, parallel design, clinical trial (one patient group receiving MDD treatment from physicians using the CDSS and the other patient group receiving usual care) conducted at 2 separate primary care clinics in Texas from March 2005 through June 2006. Fifty-five patients with MDD (DSM-IV criteria) with no significant difference in disease characteristics were enrolled, 32 of whom were treated by physicians using CDSS and 23 were treated by physicians using usual care. The study's objective was to evaluate the feasibility and efficacy of implementing a CDSS to assist physicians acutely treating patients with MDD compared to usual care in primary care. Primary efficacy outcomes for depression symptom severity were based on the 17-item Hamilton Depression Rating Scale (HDRS(17)) evaluated by an independent rater. RESULTS: Patients treated by physicians employing CDSS had significantly greater symptom reduction, based on the HDRS(17), than patients treated with usual care (P < .001). CONCLUSIONS: The CDSS algorithm, utilizing measurement-based care, was superior to usual care for patients with MDD in primary care settings. Larger randomized controlled trials are needed to confirm these findings. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT00551083.
OBJECTIVE: In 2004, results from The Texas Medication Algorithm Project (TMAP) showed better clinical outcomes for patients whose physicians adhered to a paper-and-pencil algorithm compared to patients who received standard clinical treatment for major depressive disorder (MDD). However, implementation of and fidelity to the treatment algorithm among various providers was observed to be inadequate. A computerized decision support system (CDSS) for the implementation of the TMAP algorithm for depression has since been developed to improve fidelity and adherence to the algorithm. METHOD: This was a 2-group, parallel design, clinical trial (one patient group receiving MDD treatment from physicians using the CDSS and the other patient group receiving usual care) conducted at 2 separate primary care clinics in Texas from March 2005 through June 2006. Fifty-five patients with MDD (DSM-IV criteria) with no significant difference in disease characteristics were enrolled, 32 of whom were treated by physicians using CDSS and 23 were treated by physicians using usual care. The study's objective was to evaluate the feasibility and efficacy of implementing a CDSS to assist physicians acutely treating patients with MDD compared to usual care in primary care. Primary efficacy outcomes for depression symptom severity were based on the 17-item Hamilton Depression Rating Scale (HDRS(17)) evaluated by an independent rater. RESULTS:Patients treated by physicians employing CDSS had significantly greater symptom reduction, based on the HDRS(17), than patients treated with usual care (P < .001). CONCLUSIONS: The CDSS algorithm, utilizing measurement-based care, was superior to usual care for patients with MDD in primary care settings. Larger randomized controlled trials are needed to confirm these findings. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT00551083.
Authors: Madhukar H Trivedi; A John Rush; Stephen R Wisniewski; Andrew A Nierenberg; Diane Warden; Louise Ritz; Grayson Norquist; Robert H Howland; Barry Lebowitz; Patrick J McGrath; Kathy Shores-Wilson; Melanie M Biggs; G K Balasubramani; Maurizio Fava Journal: Am J Psychiatry Date: 2006-01 Impact factor: 18.112
Authors: A John Rush; Helena C Kraemer; Harold A Sackeim; Maurizio Fava; Madhukar H Trivedi; Ellen Frank; Philip T Ninan; Michael E Thase; Alan J Gelenberg; David J Kupfer; Darrel A Regier; Jerrold F Rosenbaum; Oakley Ray; Alan F Schatzberg Journal: Neuropsychopharmacology Date: 2006-06-21 Impact factor: 7.853
Authors: Steven K Dobscha; Kathryn Corson; David H Hickam; Nancy A Perrin; Dale F Kraemer; Martha S Gerrity Journal: Ann Intern Med Date: 2006-10-03 Impact factor: 25.391
Authors: Madhukar H Trivedi; Cynthia A Claassen; Bruce D Grannemann; T Michael Kashner; Thomas J Carmody; Ella Daly; Janet K Kern Journal: Contemp Clin Trials Date: 2006-08-16 Impact factor: 2.226
Authors: M L Crismon; M Trivedi; T A Pigott; A J Rush; R M Hirschfeld; D A Kahn; C DeBattista; J C Nelson; A A Nierenberg; H A Sackeim; M E Thase Journal: J Clin Psychiatry Date: 1999-03 Impact factor: 4.384
Authors: Madhukar H Trivedi; A John Rush; Bradley N Gaynes; Jonathan W Stewart; Stephen R Wisniewski; Diane Warden; Louise Ritz; James F Luther; Diane Stegman; Joanne Deveaugh-Geiss; Robert Howland Journal: Neuropsychopharmacology Date: 2007-04-04 Impact factor: 7.853
Authors: R S Evans; S L Pestotnik; D C Classen; T P Clemmer; L K Weaver; J F Orme; J F Lloyd; J P Burke Journal: N Engl J Med Date: 1998-01-22 Impact factor: 91.245
Authors: Thomas C Baghai; Pierre Blier; David S Baldwin; Michael Bauer; Guy M Goodwin; Kostas N Fountoulakis; Siegfried Kasper; Brian E Leonard; Ulrik F Malt; Dan Stein; Marcio Versiani; Hans-Jürgen Möller Journal: Eur Arch Psychiatry Clin Neurosci Date: 2011-11 Impact factor: 5.270
Authors: Kaveh G Shojania; Alison Jennings; Alain Mayhew; Craig R Ramsay; Martin P Eccles; Jeremy Grimshaw Journal: Cochrane Database Syst Rev Date: 2009-07-08
Authors: David F Lobach; Ellis B Johns; Barbara Halpenny; Toni-Ann Saunders; Jane Brzozowski; Guilherme Del Fiol; Donna L Berry; Ilana M Braun; Kathleen Finn; Joanne Wolfe; Janet L Abrahm; Mary E Cooley Journal: JMIR Med Inform Date: 2016-11-08
Authors: Kristin Martin-Cook; Lucy Palmer; Larry Thornton; A John Rush; Carol A Tamminga; Hicham M Ibrahim Journal: Neuropsychiatr Dis Treat Date: 2021-05-25 Impact factor: 2.570
Authors: Savita Malhotra; Subho Chakrabarti; Ruchita Shah; Minali Sharma; Kanu Priya Sharma; Akanksha Malhotra; Suneet K Upadhyaya; Mushtaq A Margoob; Dar Maqbool; Gopal D Jassal Journal: Indian J Med Res Date: 2017-08 Impact factor: 2.375